Parents Shocked by Price of Children’s Hormone Drug
The parents of an 8-year-old girl were shocked when they discovered the price for a children's hormone blocker cost about [...]
HIMSS, ISPOR Partner to Bolster Membership Value
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Healthcare Information Management Systems Society (HIMSS) have partnered in a [...]
AHIP: MCO’s Generated $6.5 Billion in Medicaid Savings in 2018
A new report by America's Health Insurance Plans (AHIP) suggests managed care organizations were able to save Medicaid programs roughly [...]
ICER Announces RWE Partnership with Aetion
The Institute for Clinical and Economic Review (ICER) is partnering with Aetion to "generate decision-grade real-world evidence," the drug pricing [...]
Article Highlights Digital Healthcare Ecosystem
HEOR researcher and scientific writer Michele Cleary in the latest Value & Outcomes Spotlight featured article offers expert perspectives on [...]
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic Platform, hēRo3
Policy Analysis Inc. (PAI), a Boston-based health-economics consultancy, on Wednesday, Feb. 19, announced that it had signed a multi-year deal [...]
Wynne Health Group’s LaRosa Talks Drug Pricing Intiatives
Josh LaRosa, policy director at Wynne Health Group, in a new Relentless Health Value podcast highlights a number of drug [...]
COTA White Paper Spotlights Perspectives on RWE
A new white paper from COTA offers unique perspectives on real-world evidence (RWE), including input from Pfizer and Bristol-Myers Squibb [...]
Report Outlines How States Can Act on Drug Spending
A recent report by the Center for American Progress outlines how states can take action to reduce prescription drug spending. [...]
Rosenthal Blasts Health System, Policymakers on Surprise Bills
Journalist and physician Elisabeth Rosenthal in a recent opinion piece published on the New York Times criticizes the health care [...]
MAPS Appoints Dwyer as First Chair of New Committee
The Medical Affairs Professional Society (MAPS) appointed medical affairs consultant Mary Dwyer as the first chair of its Executive Program [...]
ISPOR-FDA Summit 2020 Nears
A joint summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Food and Drug Administration (FDA) [...]
Analysis Suggests ICER’s QALY Approach Violates ADA
A new analysis by the Pioneer Institute, "The Legality of QALY under the ADA," suggests that the Institute for Clinical [...]
MM&M Seeking Idea Pitchers for PitchSlam Events
MM&M is inviting people with a knack for pitching ideas to its upcoming PitchSlam events. The competition is for individuals [...]
AMCP CEO Cantrell Talks Health Care in 2020
Susan Cantrell, CEO of the Academy of Managed Care Pharmacy, in a recent blog post outlines a number of key [...]
NPC Study: Measurement Standards Needed to Assess Direct, Indirect Benefits of Therapies
While therapies capable of mental and physical improvements can see both direct and indirect benefits, measurement standards are necessary to [...]
ICER’s Pearson, Emond Make Case for Independent Assessments
The Institute for Clinical and Economic Review's (ICER) Steven Pearson and Sarah Emond in a recent blog post outline the [...]
Dems Invite Insulin Affordability Advocates to State of the Union
A slate of Democratic legislators have invited insulin affordability activists as their guests to tonight's State of the Union address, [...]
CVS Caremark Plan Looks to Nix Costs for Diabetes Drugs
CVS Caremark's newest option, RxZERO, looks to nix out-of-pocket costs for diabetes drugs through a number of strategies, including nudging [...]
PhRMA Announces HEOR Funding Opportunities
The PhRMA Foundation announced it is accepting applications for up to $100,000 in fellowships and grants for health outcomes research. [...]
FDA Pushes Back Deadline for Feedback on Drug Effectiveness Evidence Guide
The Food and Drug Administration (FDA) announced last week that it had extended the deadline for input on its draft [...]
A Look at California’s Plan to Make Generic Drugs
A recent report by The Sacramento Bee takes an in-depth look at California's plan to manufacture its own generic drugs [...]
SDOH Vendors Look to Build Pathways to Key Resources
New specialized vendors are taking action with social determinants of health by developing new software solutions that aim to bridge [...]
Epic Chief Urges Hospital CEOs Oppose Proposal
Epic CEO Judy Faulkner in an email sent to hospital CEOs and presidents urged recipients to rally behind the medical [...]
Is California Planning to Sell Its Own Generic Drugs?
California's Democratic Governor Gavin Newsom earlier this month proposed his potential solution to reduce drug prices: have the state manufacture [...]